Coherus Oncology Inc (CHRS)
$0.83 -7.60% Close Oct 30, 2026 Live
Coherus Oncology stock today
Coherus Oncology closed at $0.83 on October 30, 2026, down 7.60% on the day. Over the past year it returned -51.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $128 million.
$1.00$1.50$2.00$2.50
NovJan 2026MarMayJulSep
| Period | CHRS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -31.4% | -0.9% |
| 3 months | -43.5% | +2.1% |
| Year to date | -41.5% | +11.7% |
| 1 year | -51.2% | +12.4% |
| 3 years | -72.4% | +88.5% |
| 5 years | -95.0% | +76.0% |
Key statistics
- Market value
- $128M
- Price / sales
- 2.5
- 52-week range
- $0.83 to $2.51
- Next report
- Nov 9, 2026
About Coherus Oncology
Develops and commercializes oncology pharmaceutical products.
Sector: Health Care
More on Coherus Oncology
- Financials: revenue, earnings and segmentsRevenue +60% in the year to Dec 2025
- Valuation: P/E history and peers
- Returns: what $1,000 became$1,000 ten years ago is $28.92 today
No forecast, no recommendation. This page describes Coherus Oncology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.